Company Filing History:
2 out of 2 
1 out of 16 Years Active: 2019-2020
Title: Innovations by Thomas Dschietzig
Introduction
Thomas Dschietzig is a notable inventor based in Berlin, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of diabetes and heart conditions. With a total of three patents to his name, Dschietzig's work focuses on innovative therapeutic solutions that address critical health issues.
Latest Patents
One of Dschietzig's latest patents is for a pharmaceutical composition that utilizes relaxin to treat patients afflicted with impaired glucose tolerance. This invention aims to protect beta-cells and maintain beta-cell function against the detrimental effects of high blood glucose levels. Another significant patent involves a method for increasing cardiac inflow by administering a compound that binds to the relaxin receptor (RXFP1). This composition is designed for individuals suffering from heart failure with preserved ejection fraction, diastolic heart failure, or diastolic dysfunction, enhancing the heart's stroke volume at lower end-diastolic pressure.
Career Highlights
Throughout his career, Thomas Dschietzig has worked with various companies, including Relaxera Pharmaceutical Company and Immundiagnostik AG. His experience in these organizations has contributed to his expertise in developing innovative pharmaceutical solutions.
Collaborations
(Section skipped due to space constraints.)
Conclusion
Thomas Dschietzig's contributions to the pharmaceutical industry through his patents demonstrate his commitment to advancing medical treatments. His innovative approaches to managing diabetes and heart conditions highlight the importance of research and development in improving patient care.